PL2874660T3 - Preparat okulistyczny i sposób łagodzenia starczowzroczności - Google Patents
Preparat okulistyczny i sposób łagodzenia starczowzrocznościInfo
- Publication number
- PL2874660T3 PL2874660T3 PL13745508T PL13745508T PL2874660T3 PL 2874660 T3 PL2874660 T3 PL 2874660T3 PL 13745508 T PL13745508 T PL 13745508T PL 13745508 T PL13745508 T PL 13745508T PL 2874660 T3 PL2874660 T3 PL 2874660T3
- Authority
- PL
- Poland
- Prior art keywords
- ophthalmic formulation
- presbyopia
- ameliorating
- ameliorating presbyopia
- ophthalmic
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 201000010041 presbyopia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/553,615 US10507245B2 (en) | 2012-07-19 | 2012-07-19 | Ophthalmic formulation and method for ameliorating presbyopia |
| PCT/US2013/051153 WO2014015183A1 (en) | 2012-07-19 | 2013-07-18 | Ophthalmic formulation and method for ameliorating presbyopia |
| EP13745508.5A EP2874660B1 (en) | 2012-07-19 | 2013-07-18 | Ophthalmic formulation and method for ameliorating presbyopia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2874660T3 true PL2874660T3 (pl) | 2019-07-31 |
Family
ID=48917698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13745508T PL2874660T3 (pl) | 2012-07-19 | 2013-07-18 | Preparat okulistyczny i sposób łagodzenia starczowzroczności |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10507245B2 (pl) |
| EP (1) | EP2874660B1 (pl) |
| CN (2) | CN113425715A (pl) |
| AR (2) | AR092860A1 (pl) |
| BR (1) | BR112015001158B1 (pl) |
| CO (1) | CO7250451A2 (pl) |
| DK (1) | DK2874660T3 (pl) |
| ES (1) | ES2719250T3 (pl) |
| HR (1) | HRP20190627T1 (pl) |
| MX (1) | MX351230B (pl) |
| PL (1) | PL2874660T3 (pl) |
| PT (1) | PT2874660T (pl) |
| RU (1) | RU2657514C2 (pl) |
| TR (1) | TR201905683T4 (pl) |
| WO (1) | WO2014015183A1 (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014CN02961A (pl) | 2011-09-20 | 2015-07-03 | Altavista Inst De Invest Medica S A S | |
| ES2538551B1 (es) * | 2013-12-20 | 2016-01-13 | Eurocanarias Oftalmológica, Sl | Composición Oftálmica para la corrección de la presbicia |
| EP3104851A1 (en) * | 2014-02-11 | 2016-12-21 | Orasis Pharmaceuticals Ltd. | Pharmacological ophthalmic composition for use in the correction of presbyopia and its administration |
| CN104856990A (zh) * | 2015-05-07 | 2015-08-26 | 武汉武药科技有限公司 | 去氧肾上腺素酮咯酸溶液及制备方法 |
| US20190000808A1 (en) * | 2015-07-13 | 2019-01-03 | Allergan, Inc. | Composition and methods for the treatment of blephopharoptosis |
| CH711969A2 (it) * | 2015-12-29 | 2017-06-30 | Pinelli Roberto | Composizione per il trattamento della presbiopia. |
| KR102472774B1 (ko) * | 2016-08-19 | 2022-11-30 | 오라시스 파마슈티칼스 엘티디. | 안과용 약학 조성물 및 이와 관련된 용도 |
| US20180318319A1 (en) | 2017-05-04 | 2018-11-08 | Ocular Science, Inc. | Compositions and Methods for Treating Eyes and Methods of Preparation |
| EP3749303A4 (en) * | 2018-02-05 | 2022-01-26 | Cellixbio Private Limited | COMBINATION OF AN ANTIMUSCARINE OR ANTICCHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF |
| US20190321334A1 (en) * | 2018-04-19 | 2019-10-24 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
| JP6946575B2 (ja) | 2018-04-24 | 2021-10-06 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 眼の状態の治療のためのピロカルピン塩酸塩の使用 |
| US11077053B2 (en) | 2018-08-21 | 2021-08-03 | Allergan, Inc. | Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia |
| EP3840750A1 (en) * | 2018-08-21 | 2021-06-30 | Allergan, Inc. | The use of alpha-2-adrenergic receptor agonists for improving vision |
| JP2022508715A (ja) | 2018-10-15 | 2022-01-19 | オキュフィア・ファーマ・インコーポレイテッド | 緑内障および関連状態の処置のための方法および組成物 |
| DK3870170T3 (da) | 2018-10-26 | 2026-05-26 | Opus Genetics Inc | Behandling af presbyopi og mydriasis med fentolamin |
| US11071724B2 (en) * | 2019-05-17 | 2021-07-27 | Ocular Science, Inc. | Compositions and methods for treating presbyopia |
| EP3980017A4 (en) * | 2019-06-10 | 2023-06-28 | Visus Therapeutics, Inc. | Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality |
| MX394625B (es) * | 2020-11-12 | 2025-03-24 | Cesar Alejandro Sanchez Galeana | Composicion oftalmologica sinergica en dosis de baja concentracion eficaz en la prevencion, control y erradicacion de la presbicia |
| CN115368310B (zh) | 2021-05-18 | 2025-06-27 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
| WO2023086878A1 (en) | 2021-11-10 | 2023-05-19 | Visus Therapeutics, Inc. | Carbachol formulations to enhance anti-presbyopia effects |
| CN116270442B (zh) * | 2021-12-21 | 2025-07-01 | 浙江瑞瞳生物科技有限公司 | 一种用于矫正近距离视力的眼用制剂 |
| US20250127760A1 (en) * | 2021-12-28 | 2025-04-24 | Shenyang Xingqi Pharmaceutical Co., Ltd. | Composition and use thereof in preparation of medicament for treating presbyopia |
| CN118236372A (zh) * | 2023-03-07 | 2024-06-25 | 温州医科大学附属眼视光医院 | 治疗近视的药物和方法 |
| MX2023011567A (es) * | 2023-09-28 | 2025-04-02 | Centro De Retina Medica Y Quirurgica S C | Formulacion topica oftalmica de base lipidica para hacer mas eficiente la penetracion de las barreras del globo ocular de los bioactivos pilocarpina, cumarina escopoletina y patuletina presentes en el extracto de pilocarpus jaborandi y su uso en la conservacion de la salud del cristalino |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474751A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
| DK335086A (da) | 1985-08-05 | 1987-02-06 | Michele Testa | Kemiske sammensaetninger og farmaceutiske praeparater til topisk brug indeholdende mindst en af de kemiske sammensaetninger i en terapeutiskvirksom maengde |
| US4902696A (en) * | 1987-10-08 | 1990-02-20 | Hoechst-Roussel Pharmaceuticals, Inc. | Synergistic intraocular pressure lowering combinations |
| US5192780A (en) * | 1989-12-18 | 1993-03-09 | Alcon Laboratories, Inc. | Methods using antiallergics and antihistamines |
| US5041434A (en) * | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| US5459133A (en) | 1992-06-05 | 1995-10-17 | Telor Ophthalmic Pharmaceuticals, Inc. | Methods and products for treating presbyopia |
| US5624962A (en) * | 1993-04-16 | 1997-04-29 | Wakamoto Pharmaceutical Co., Ltd. | Aqueous drug composition having property of reversible thermosetting gelation |
| US5677321A (en) | 1996-02-29 | 1997-10-14 | Synaptic Pharmaceutical Corporation | 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands |
| IT1306135B1 (it) * | 1999-04-26 | 2001-05-30 | Farmigea Spa | Composizioni oftalmiche per il trattamento delle turbe visivecaratterizzate da ridotta sensibilita' al contrasto. |
| US20050261641A1 (en) | 2002-09-26 | 2005-11-24 | Warchol Mark P | Method for ophthalmic administration of medicament |
| US20060172972A1 (en) | 2002-12-20 | 2006-08-03 | Chakshu Research Inc | Formulation and method for administration of ophthalmologically active agents |
| US20060177430A1 (en) | 2002-12-20 | 2006-08-10 | Chakshu Research Inc | Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer |
| US20060166879A1 (en) | 2002-12-20 | 2006-07-27 | Chakshu Research Inc | Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| WO2004058289A1 (en) | 2002-12-20 | 2004-07-15 | Chakshu Research, Inc. | Ophthalmic formulation for the prevention and treatment of ocular conditions |
| US7252662B2 (en) | 2004-11-02 | 2007-08-07 | Lenticular Research Group Llc | Apparatus and processes for preventing or delaying one or more symptoms of presbyopia |
| ATE439863T1 (de) | 2006-12-18 | 2009-09-15 | Jorge Luis Benozzi | Ophthalmische zusammensetzungen von parasympathischen stimulantia und entzündungshemmer zur verwendung bei der behandlung von presbyopie |
| GB0724558D0 (en) | 2007-12-15 | 2008-01-30 | Sharma Anant | Optical correction |
| TNSN08110A1 (en) | 2008-03-11 | 2009-07-14 | Rekik Raouf Dr | Drug delivery to the anterior and posterior segment of the eye from drops |
| TWI542338B (zh) | 2008-05-07 | 2016-07-21 | 壯生和壯生視覺關懷公司 | 用於活性劑之控制釋放的眼用裝置 |
| WO2010125416A1 (en) | 2009-04-27 | 2010-11-04 | Raouf Rekik | Drug delivery to the anterior and posterior segments of the eye |
| US8299079B2 (en) * | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| US20100298335A1 (en) | 2009-05-22 | 2010-11-25 | Kaufman Herbert E | Preparations and Methods for Ameliorating or Reducing Presbyopia |
| AU2010302350B2 (en) | 2009-10-02 | 2015-06-18 | Journey Medical Corporation | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US20120245505A1 (en) | 2009-12-16 | 2012-09-27 | Robinson Michael R | Intracameral devices for sustained delivery |
| US20110301555A1 (en) | 2010-06-03 | 2011-12-08 | Gonzalez-Zugasti Javier P | Porous matrix drug core for lacrimal insert device |
| US20120003296A1 (en) | 2010-07-01 | 2012-01-05 | Shantha Totada R | New methods of treating dry eye syndrome |
| IN2014CN02961A (pl) | 2011-09-20 | 2015-07-03 | Altavista Inst De Invest Medica S A S |
-
2012
- 2012-07-19 US US13/553,615 patent/US10507245B2/en active Active
-
2013
- 2013-07-18 CN CN202110595122.XA patent/CN113425715A/zh active Pending
- 2013-07-18 WO PCT/US2013/051153 patent/WO2014015183A1/en not_active Ceased
- 2013-07-18 ES ES13745508T patent/ES2719250T3/es active Active
- 2013-07-18 CN CN201380043978.XA patent/CN104717981A/zh active Pending
- 2013-07-18 EP EP13745508.5A patent/EP2874660B1/en active Active
- 2013-07-18 TR TR2019/05683T patent/TR201905683T4/tr unknown
- 2013-07-18 BR BR112015001158-6A patent/BR112015001158B1/pt not_active IP Right Cessation
- 2013-07-18 MX MX2015000806A patent/MX351230B/es active IP Right Grant
- 2013-07-18 PT PT13745508T patent/PT2874660T/pt unknown
- 2013-07-18 DK DK13745508.5T patent/DK2874660T3/en active
- 2013-07-18 PL PL13745508T patent/PL2874660T3/pl unknown
- 2013-07-18 RU RU2015102531A patent/RU2657514C2/ru active
- 2013-07-18 HR HRP20190627TT patent/HRP20190627T1/hr unknown
- 2013-07-19 AR ARP130102572A patent/AR092860A1/es not_active Application Discontinuation
-
2015
- 2015-01-28 CO CO15017205A patent/CO7250451A2/es unknown
-
2019
- 2019-12-03 US US16/701,602 patent/US20200237916A1/en not_active Abandoned
-
2021
- 2021-04-14 AR ARP210100987A patent/AR121843A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR201905683T4 (tr) | 2019-05-21 |
| RU2015102531A (ru) | 2016-09-10 |
| AR092860A1 (es) | 2015-05-06 |
| EP2874660B1 (en) | 2019-01-23 |
| CO7250451A2 (es) | 2015-04-30 |
| HRP20190627T1 (hr) | 2019-06-14 |
| ES2719250T3 (es) | 2019-07-09 |
| BR112015001158A2 (pt) | 2017-06-27 |
| MX2015000806A (es) | 2015-08-10 |
| WO2014015183A1 (en) | 2014-01-23 |
| PT2874660T (pt) | 2019-05-14 |
| MX351230B (es) | 2017-10-06 |
| US10507245B2 (en) | 2019-12-17 |
| CN104717981A (zh) | 2015-06-17 |
| CN113425715A (zh) | 2021-09-24 |
| RU2657514C2 (ru) | 2018-06-14 |
| EP2874660A1 (en) | 2015-05-27 |
| DK2874660T3 (en) | 2019-04-15 |
| BR112015001158B1 (pt) | 2020-12-15 |
| US20200237916A1 (en) | 2020-07-30 |
| AR121843A2 (es) | 2022-07-13 |
| US20140024642A1 (en) | 2014-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2874660T (pt) | Formulação oftálmica e respectivo uso e método para melhorar, reduzir ou tratar presbio-pia | |
| PL2845534T3 (pl) | Aparat okulistyczny | |
| SG11201500606UA (en) | Patient interface and method for making same | |
| GB2500915B (en) | Arrangement and method | |
| EP2929413A4 (en) | PORTABLE EYE TRACKING DEVICES AND METHODS OF USE | |
| SG11201405687QA (en) | Lens for myopic eye | |
| SG10201609812SA (en) | System and process for retina phototherapy | |
| EP2817018A4 (en) | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS | |
| EP2885380A4 (en) | HYDROGEN TREATMENT METHOD AND DEVICE THEREFOR | |
| PL2820471T3 (pl) | Metoda i system ulepszający receptę okulistyczną | |
| EP2907501A4 (en) | BEAUTY CARE PROCESS | |
| EP2822505A4 (en) | IMPROVED POLYMERS AND METHODS FOR OPHTHALMIC APPLICATIONS | |
| IL237586A0 (en) | Prosthesis for increasing the opening of the eye and method | |
| EP2922511A4 (en) | TREATMENT DEVICE FOR EYELID | |
| SG11201501838RA (en) | Completion assembly and methods for use thereof | |
| EP2822307A4 (en) | METHOD AND DEVICE FOR LOADING | |
| EP2907500A4 (en) | BEAUTY CARE PROCESS | |
| SG11201501731UA (en) | System and method for manufacturing ophthalmic devices | |
| EP2835682A4 (en) | PROGRESSIVE POWER LENS AND METHOD OF DESIGNING PROGRESSIVE POWER LENS | |
| EP2819667B8 (en) | Retinal derivatives for use in improving visual function | |
| SG11201408326TA (en) | Preparation method for perfluoro-2-methyl-3-pentanone and intermediate | |
| EP2914515A4 (en) | METHOD AND PLANT FOR A WAREHOUSE | |
| PL2805796T3 (pl) | Sposób szlifowania | |
| EP2937729A4 (en) | METHOD AND PRODUCTION DEVICE FOR GLASSES OF GLASSES | |
| EP2891464A4 (en) | THERAPEUTIC AGENT AND THERAPEUTIC PROCESS |